Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health

Generated: December 17, 2017

Montenegro Drug Patents

These international patent data are derived from patent families, based on US drug-patent linkages.
They should not be regarded as comprehensive records of ex-US drug-patent associations.

Document Number Estimated Expiration Equivalent US Patent US Expiry Date Generic Name US Applicant US Tradename
00592► Subscribe9393237Aug 4, 2026paroxetine mesylateSebela Ireland LtdBRISDELLE
00592► Subscribe8658663Apr 6, 2029paroxetine mesylateSebela Ireland LtdBRISDELLE
00592► Subscribe8946251Aug 4, 2026paroxetine mesylateSebela Ireland LtdBRISDELLE
P34408► Subscribe9271968Feb 27, 2026rifaximinSalix PharmsXIFAXAN
P34408► Subscribe8193196Sep 2, 2027rifaximinSalix PharmsXIFAXAN
P34408► Subscribe8741904Feb 27, 2026rifaximinSalix PharmsXIFAXAN
P34408► Subscribe8518949Feb 27, 2026rifaximinSalix PharmsXIFAXAN
P50808► Subscribe8426586Oct 10, 2029afatinib dimaleateBoehringer IngelheimGILOTRIF
P50608► Subscribe7932273Sep 7, 2025dabigatran etexilate mesylateBoehringer IngelheimPRADAXA
00564► Subscribe7737142Mar 27, 2027cariprazine hydrochlorideForest Res Inst IncVRAYLAR
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Federal Trade Commission
Harvard Business School
Queensland Health
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: